Invesco Pharmaceuticals ETF
PJP
96 hedge funds and large institutions have $110M invested in Invesco Pharmaceuticals ETF in 2017 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 42 reducing their positions, and 16 closing their positions.
25% more call options, than puts
Call options by funds: $621K | Put options by funds: $495K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.46% less ownership
Funds ownership: 15.84% → 14.37% (-1.5%)
5% less funds holding
Funds holding: 101 → 96 (-5)
18% less capital invested
Capital invested by funds: $134M → $110M (-$24.2M)
19% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 16
64% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 42
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$1.63M |
| 2 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$1.56M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$842K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$685K |
| 5 |
PAM
Peak Asset Management
Louisville,
Colorado
|
+$441K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$9.9M |
| 2 |
VFA
Voya Financial Advisors
Windsor,
Connecticut
|
-$2.89M |
| 3 |
Chevy Chase Trust
Bethesda,
Maryland
|
-$2.62M |
| 4 |
M&T Bank
Buffalo,
New York
|
-$2.33M |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$2.05M |
PJP Hedge Fund Activity: Q1 2017 in Review
96 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q1 2017, worth a combined $110M — down 18% from $134M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of PJP and 13 opened new positions — a net loss of 3 holders — while 42 trimmed existing stakes and 15 added.
The largest buyer was Citadel Advisors, adding an estimated $1.63M. The largest seller was Bank of America, cutting an estimated $9.9M.
- 96 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q1 2017, down from 101 in Q4 2016.
- Funds reported $110M of Invesco Pharmaceuticals ETF stock for Q1 2017, down 18% quarter-over-quarter.
- 13 funds opened new Invesco Pharmaceuticals ETF positions in Q1 2017 and 16 closed out, a net change of -3 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q1 2017 was Citadel Advisors, an estimated $1.63M added.
- The largest Invesco Pharmaceuticals ETF seller in Q1 2017 was Bank of America, an estimated $9.9M sold.
Based on aggregated 13F filings for Q1 2017.